Guanhao Biotech Co Ltd Strategic Asset Allocation Index
Guanhao Biotech Co Ltd strategic asset allocation index. Guanhao Biotech Co Ltd (300238) has a Strategic Asset Allocation Index of 46.4% as of June 2023. Strategic assets (PP&E of CN¥214.29 Million plus long-term investments of CN¥-) total CN¥214.29 Million, measured against net assets of CN¥462.30 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Guanhao Biotech Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Guanhao Biotech Co Ltd (2008–2021)
Strategic asset allocation index of Guanhao Biotech Co Ltd from 2008 to 2021. This chart shows how Guanhao Biotech Co Ltd's Strategic Asset Allocation Index has evolved across 14 annual periods from 2008 to 2021. As of June 2023, the index stands at 46.4%, representing strategic assets of CN¥214.29 Million against net assets of CN¥462.30 Million CNY.
Guanhao Biotech Co Ltd Strategic Asset Allocation Index by Year (2008–2021)
Guanhao Biotech Co Ltd strategic asset allocation index by year from 2008 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Guanhao Biotech Co Ltd from 2008 to 2021, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Guanhao Biotech Co Ltd.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 32.8% | CN¥245.54 Million | CN¥245.54 Million | CN¥- | CN¥748.16 Million | ▲ +2.0 pp |
| 2020 | 30.8% | CN¥220.63 Million | CN¥220.63 Million | CN¥- | CN¥716.66 Million | ▼ -2.8 pp |
| 2019 | 33.6% | CN¥236.51 Million | CN¥236.51 Million | CN¥- | CN¥704.14 Million | ▲ +11.5 pp |
| 2018 | 22.1% | CN¥254.88 Million | CN¥254.88 Million | CN¥- | CN¥1.16 Billion | ▼ -0.3 pp |
| 2017 | 22.4% | CN¥271.42 Million | CN¥271.42 Million | CN¥- | CN¥1.21 Billion | ▲ +8.1 pp |
| 2016 | 14.2% | CN¥207.64 Million | CN¥207.64 Million | CN¥- | CN¥1.46 Billion | ▼ -18.8 pp |
| 2015 | 33.1% | CN¥205.30 Million | CN¥205.30 Million | CN¥- | CN¥620.62 Million | ▼ -6.9 pp |
| 2014 | 40.0% | CN¥212.39 Million | CN¥212.39 Million | CN¥- | CN¥531.61 Million | ▼ -5.6 pp |
| 2013 | 45.6% | CN¥227.03 Million | CN¥227.03 Million | CN¥- | CN¥498.16 Million | ▼ -3.5 pp |
| 2012 | 49.1% | CN¥222.76 Million | CN¥222.76 Million | CN¥- | CN¥454.11 Million | ▲ +18.1 pp |
| 2011 | 31.0% | CN¥134.10 Million | CN¥134.10 Million | CN¥- | CN¥432.79 Million | ▼ -31.6 pp |
| 2010 | 62.6% | CN¥90.79 Million | CN¥90.79 Million | CN¥- | CN¥144.99 Million | ▲ +27.9 pp |
| 2009 | 34.7% | CN¥26.71 Million | CN¥26.71 Million | CN¥- | CN¥76.95 Million | ▲ +23.1 pp |
| 2008 | 11.6% | CN¥4.30 Million | CN¥4.30 Million | CN¥- | CN¥37.01 Million | — |